All stock lists
Unlock the score
Neuraxis, INC (New York Stock Exchange Arca:NRXS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
7.32-0.08 (-1.08%)
Insider Score
/ 100
NRXS Insider Score
Neuraxis, INC has a live Insider Score.
Scored on 3 qualifying trades from 3 insiders in the last 90 days.
NRXS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.93 M | 1.61 M | 968.13 K | 811.41 K | 894.09 K | 895.65 K |
| Revenue Growth (YoY) | 115.72 % | 79.52 % | 27.19 % | 21.72 % | 46.21 % | 38.51 % |
| Cost of Revenue | 272.57 K | 218.37 K | 141.31 K | 135.49 K | 146.64 K | 139.47 K |
| Gross Profit | 1.66 M | 1.39 M | 826.82 K | 675.93 K | 747.44 K | 756.18 K |
| SG&A Expense | 3.51 M | 3.03 M | 2.30 M | 2.65 M | 2.41 M | 2.99 M |
| R&D Expense | 274.34 K | 99.57 K | 243.89 K | 130.85 K | 58.32 K | 60.56 K |
| Operating Expenses | 3.78 M | 3.13 M | 2.54 M | 2.78 M | 2.47 M | 3.05 M |
| Operating Income | -2.12 M | -1.74 M | -1.72 M | -2.10 M | -1.72 M | -2.30 M |
| Pretax Income | -2.09 M | -1.76 M | -1.71 M | -2.12 M | -1.69 M | -2.28 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -2.28 M | -1.76 M | -1.71 M | -2.12 M | -1.69 M | -2.28 M |
| EPS (Basic) | -0.19 | -0.18 | -0.16 | -0.24 | -0.22 | -0.33 |
| EPS (Diluted) | -0.19 | -0.18 | -0.16 | -0.24 | -0.22 | -0.33 |
| Shares Outstanding | 12.12 M | 10.95 M | 9.08 M | 9.88 M | 8.52 M | 7.46 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.